Accredo Health's ( ACDO) fourth-quarter earnings rose sharply from a year ago despite a big restructuring charge, beating First Call/Thomson Financial estimates significantly. The addition of new products contributed to the company's increased earnings. Including the charge, the company earned $7.7 million, or 27 cents a share, in the quarter ended June 30, up from $4.9 million, or 18 cents a share, a year ago. Revenue rose to $188.2 million from $124.4 million a year ago Before restructuring charges, the company earned $10.0 million, or 36 cents a share, and excluding the results of its recently acquired Specialty Pharmaceutical Services division, the company earned $8.72 million, or 32 cents a share. First Call/Thomson Financial analysts had predicted the company to earn 29 cents a share. The company said gross profit margins increased to 18.6% for the latest quarter compared with a 14.8% improvement in last year's comparable quarter. Restructuring charges included a $3.55 million software write-off and $340,000 in lease commitments that will be abandoned because the company will join facilities with SPS. Looking ahead, Accredo confirmed that it expects to have $1.45 billion to $1.5 billion in revenue for the year and an EPS of $1.87 to $1.97 a share. First Call/Thomson Financial analysts have predicted the company to earn 36 cents a share for the first quarter and $1.94 for the year. The shares were recently rising 35 cents to $53.31.